DrNeal Bangerter
Visiting Professor
Department of Bioengineering - Faculty of Engineering
- Visiting ProfessorDepartment of Bioengineering - Faculty of Engineering
- 3.15, Royal School of Mines, South Kensington Campus, United Kingdom
BIO
Dr. Neal Bangerter is a Visiting Professor in Imperial College London’s Department of Bioengineering and Professor of Electrical and Computer Engineering at Boise State University, where he recently served as Head of Department/Department Chair. His work spans artificial intelligence and machine learning, medical imaging—with a particular focus on MRI—data analytics, and signal processing. His career combines academic research and education with experience in technology strategy, both customer-facing and technical product management, consulting and entrepreneurship. As Head of Department at Boise State University, he oversaw 40% year-on-year growth in student enrollments in the department, hired seven tenure-track faculty, oversaw the restructuring of the curriculum, developed significant industry partnerships, and helped build both the research and teaching stature of the department.
Dr. Bangerter originally joined Imperial full time in early 2018 as Associate Professor (Reader) of Bioengineering. He previously served as Imperial’s lead for the London Collaborative Ultra-High Field Scanner (LOCUS) project, a joint venture involving King’s College London, Imperial, University College London and the Institute for Cancer Research. He also served as director of master's programs at Imperial for the Department of Bioengineering. He is affiliated with the Imperial Artificial Intelligence Network and the Computation, Cognitive, and Clinical Neuroimaging Laboratory. Along with Dr. Pete Lally, he continues running an active reseearch program and mentoring Ph.D. students at Imperial.
Alongside his academic work, Dr. Bangerter has helped organisations assess emerging technologies, develop products and identify practical applications of AI and machine learning. During a year on leave from Imperial, he helped build Cognizant’s Artificial Intelligence Practice in Healthcare and Life Sciences across Europe. His earlier industry roles include consulting in McKinsey & Company’s technology practice, business development and product strategy at Microsoft, and Vice President of Product Management at interactive advertising technology company Reactrix. At Microsoft, his work included market research, product planning and strategic partnerships; at Reactrix, he led product strategy and negotiated and managed partnerships with Samsung and other technology companies.
His industry experience began before graduate school, when he worked in software development for metrology company Wilcox Associates and co-founded the data visualisation software company Visualize. These roles provided experience in software engineering, business development and bringing new technologies to market.
Dr. Bangerter received his Bachelor’s degree in Physics from the University of California, Berkeley, and his Master’s and Ph.D. degrees in Electrical Engineering from Stanford University. His doctoral research focused on developing fast MRI techniques. His subsequent academic appointments included research in Stanford’s Radiological Sciences Laboratory and a decade in Brigham Young University’s Department of Electrical and Computer Engineering before joining Imperial. At BYU, he held the David Evans Chair, founded the Medical Imaging Research Center, and helped develop the cross-faculty Crocker Innovation Fellowship Program pioneered in the Marriott School of Management. He was a Visiting Scholar at the University of Oxford in 2014–2015 and holds adjunct or courtesy appointments in executive education at INSEAD, radiology and orthopaedics at the University of Utah, and electrical engineering at Brigham Young University.
His research interests include AI and machine learning for biotech, medical imaging,and healthcare, novel MRI acquisition and reconstruction methods, and pulse sequence development at ultra-high magnetic field strengths. More broadly, he is interested in the capabilities and limitations of AI and data-driven methods across the biosciences, healthcare and other industries. He contributed to establishing the UK Biobank neuroimaging study, helping develop imaging methods for a large-scale population health research programme. His research collaborations have included groups at Stanford, Oxford, Cambridge, the Institute for Cancer Research, the University of Utah, Brigham Young University, King’s College London and Siemens Healthcare.
Dr. Bangerter regularly teaches executive education at INSEAD, helping senior leaders understand the technical foundations of AI and their implications for business strategy, innovation and digital transformation. He served as an AI expert on EFG Asset Management’s Future Leaders Panel in London and has addressed executive and investment audiences on AI and healthcare technology, including at the EFG New Capital Investment Summit and the Cayman Investment Forum. His advisory work includes Robocap’s Advisory Board (Robocap is an AI and robotics investment fund absed in London) and Chondrometrics’ Scientific Advisory Board. (Chondrometrics supports clinical trials in osteoarhtritis and is based in Freilassing, Germany). He also consults on artificial intelligence, the strategic use of data, digital transformation in complex organizations, and innovation and intellectual property, drawing on experience working across scientific, engineering and commercial disciplines.
FACULTY
- Faculty of Engineering
POSITION NAME
- Visiting Professor